DeOndra Dixon INCLUDE Project Act of 2026
Summary
The DeOndra Dixon INCLUDE Project Act of 2026 authorizes a Down syndrome research program at NIH but does not appropriate specific funds. It passed the Senate by voice vote on August 6, 2026, and now awaits House action. The bill has no direct near-term market impact due to its authorization-only nature and lack of specified funding.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.The bill authorizes a Down syndrome research program at NIH but does not appropriate funds.
- 2.Passed Senate by voice vote; House action is the next step.
- 3.No direct near-term impact on publicly traded companies due to lack of funding and specificity.
Market Implications
The bill has no material market implications. It does not create revenue streams for any publicly traded company. Investors should not expect any stock movement based on this legislation.
Full Analysis
The bill, S.1838, passed the Senate on August 6, 2026, by voice vote with an amendment in the nature of a substitute. It is now awaiting action in the House. The legislation amends the Public Health Service Act to authorize the Secretary of Health and Human Services, through the NIH Office of the Director, to carry out a program of research, training, and investigation related to Down syndrome, known as the INCLUDE Project. The bill includes findings on Down syndrome prevalence and co-occurring conditions but does not specify an authorized funding amount. As an authorization bill, it sets policy and spending ceilings but does not allocate actual money; separate appropriations legislation would be required to fund the program. The bipartisan sponsorship (9 cosponsors including Republicans and Democrats) and unanimous consent passage in the Senate indicate broad support, but the lack of a House companion bill and the procedural nature of authorization limit immediate market relevance. No specific companies or sectors beyond healthcare research are directly affected, and the bill does not create procurement or contracting opportunities for publicly traded firms. The legislative path forward requires House passage and presidential signature, but even then, funding depends on future appropriations.
Key Legislators
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
STATE OF FLORIDA DIVISION OF EMERGENCY MANAGEMENT: $2.9B Department of Homeland Security Grant
STATE OF FLORIDA DIVISION OF EMERGENCY MANAGEMENT: $1.5B Department of Homeland Security Grant
GEORGIA EMERGENCY MANAGEMENT AND HOMELAND SECURITY AGENCY: $1.6B Department of Homeland Security Grant
GOVERNOR'S AUTHORIZED REPRESENTATIVE: $1.8B Department of Homeland Security Grant
NORTH CAROLINA DEPARTMENT OF PUBLIC SAFETY: $2.4B Department of Homeland Security Grant
HEALTH CARE SERVICES, CALIFORNIA DEPARTMENT OF: $6.0B Department of Health and Human Services Grant
DEPARTMENT OF SOCIAL SERVICES CONNECTICUT: $6.9B Department of Health and Human Services Grant
STATE OF COLORADO - DEPT OF HEALTH CARE POLICY & FINANCING: $9.2B Department of Health and Human Services Grant
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Continuing to Protect the Meaning and Value of American Citizenship
This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.
Ending Birth Tourism
This executive order directs the Secretaries of State and Homeland Security to prevent foreign nationals from entering the U.S. on nonimmigrant visas for the purpose of giving birth (birth tourism), including revoking visas, barring entry, and taking action against facilitators. It defines birth tourism as entry via nonimmigrant visa for childbirth and allows humanitarian or national interest exemptions.
Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security
President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →